default author photo

Pauline du Rusquec

Institut Curie - Department of Drug Development and Innovation (D3i)

Paris & Saint-Cloud

France

SCHOLARLY PAPERS

2

DOWNLOADS

101

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Risks and Benefits of Anticancer Drugs in Advanced Cancer Patients: A Systematic Review and Meta-Analysis

Number of pages: 22 Posted: 13 Apr 2021
Camille Moreau Bachelard, Elodie Coquan, Pauline du Rusquec, Xavier Paoletti, Xavier Paoletti and Christophe Le Tourneau
Institut Curie - Department of Drug Development and Innovation (D3i), Centre François Baclesse - Department of Medical Oncology, Institut Curie - Department of Drug Development and Innovation (D3i), Institut Curie - Department of BiostatisticsUniversity of Paris - Faculty of Medicine Paris and Institut Curie - Department of Drug Development and Innovation (D3i)
Downloads 61 (970,490)

Abstract:

Loading...

2.

Palliative Care Integration and End-of-Life Care Intensity for Patients with Nsclc

Number of pages: 16 Posted: 11 Jan 2024
Alice Martin, Matthieu Carton, Laura Thery, Alexis Burnod, Catherine Daniel, Pauline du Rusquec, Nicolas Girard and Carole Bouleuc
PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Institut Curie - Department of Drug Development and Innovation (D3i), PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 40 (1,196,171)

Abstract:

Loading...

metastatic non-small cell lung cancer, end-of-life care, palliative care, systemic cancer treatment discontinuation